Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are suspected of having lung cancer or a lung nodule, stomach cancer or a stomach lesion, or colorectal cancer or a colorectal lesion.
- People who have signed a consent form agreeing to take part in the trial.
- People who have complete and detailed medical records, including imaging scans, pathology reports, and other important health information on file.
- Healthy people who have not been diagnosed with lung cancer or a lung nodule, stomach cancer or a stomach lesion, or colorectal cancer or a colorectal lesion.
Who may not be able to join:
- People whose key medical or pathology records are missing or incomplete.
- People who are unable to be contacted or followed up with over the course of the trial.
- People whose medical scans or images are too low in quality to be properly analysed by the research team.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yang Jin, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phone: +86 15827125538
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The outcome of clinical diagnosis of suspected patients with lung cancer/pulmonary nodular (Benign/Malignant nodule); The outcome of clinical diagnosis of suspected patients with colorectal cancer or lesion (Benign/Malignant).; Treatment response of anti-cancer therapy at first evaluation in patients with lung/stomach/colorectal cancer (CR, PR, PD, SD).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.